Miles Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Miles Capital's AMGN Position: Q3 2019 in Review
Miles Capital sold out of Amgen (AMGN) in Q3 2019, closing a stake of 4,509 shares — an estimated $831K sold.
Miles Capital first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $911K in Q4 2018. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Miles Capital reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
- Miles Capital sold 4,509 Amgen shares in Q3 2019, an estimated $831K.
- Miles Capital first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
- Miles Capital's Amgen position peaked at $911K in Q4 2018.
- 1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Miles Capital's 13F filing for Q3 2019, filed 7 Nov 2019.